References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Christensenetal(2003)Aselectivesmallmoleculeinhibitorofc-Metkinaseinhibitsc-Met-dependentphenotypesinvitroandexhibitscytoreductiveantitumouractivityinvivo.CancerRes.637345PMID:14612533
Purietal(2007)Aselectivesmallmoleculeinhibitorofc-Met,PHA665752,inhibitstumorigenicityandangiogenesisinmouselungcancerxenografts.CancerRes.673529PMID:17440059
Tuetal(2010)Efficacyofc-Metinhibitorforadvancedprostatecancer.BMCCancer10556PMID:20946682
Smolenetal(2006)AmplificationofMETmayidentifyasubsetofcancerswithextremesensitivitytotheselectivetyrosinekinaseinhibitorPHA-665752.Proc.Natl.Acad.Sci.USA1032316PMID:
Keywords:PHA665752,supplier,Potent,selective,cMET,inhibitors,inhibits,Hepatocyte,Growth,Factors,Receptors,HGFR,Receptor,Tyrosine,Kinases,RTKs,PHA665752,Pfizer,MET,Receptors,MET,Receptors,TocrisBioscience